OBN BioTuesday: ‘A Spotlight on the latest R&D in the Metabolic Disease and Obesity Space’

This event will focus on the latest advancements in metabolic disease and obesity research. Attendees can expect insightful presentations from experts across Big Pharma, patient advocacy, and R&D SMEs working in Diagnostics, Medtech, and Therapeutics.

Keynote speakers include Matthew Coghlan from Eli Lilly, Giorgio Gissey from Keyron Medical Technology, and Adrien Lemoine from Bloomsbury Genetic Therapies, among others. The event will also feature a Q&A session and ample networking opportunities. Designed for professionals in the life sciences sector, BioTuesday offers a platform for knowledge sharing and connecting with peers to discuss cutting-edge innovations in obesity and metabolic disease treatment.